Does genetic makeup of an individual influence patient's vulnerability to an opioid use disorder?

Knowledge Library published on May 31, 2013 in Assess & Monitor
Download Transcript Download Audio
Kathryn L. Hahn, PharmD, DAAPM, CPE
Affiliate Faculty
Oregon State University College of Pharmacy
Springfield, Oregon
Hi. I am Kathy Hahn. I am a community pharmacist and I have been specializing in pain management for the last 20 years or so. I am in Eugene, Oregon and I am affiliate faculty at Oregon State University School of Pharmacy and I am also on the board of directors for the American Academy of Pain Management. Genetic makeup actually is pretty interesting and I think Lynn Webster quoted a study a little earlier in our program talking about how important family history of drug abuse and diversion and addiction and all that is in looking at someone who has problems. In the pharmacy setting, we actually are able to look at patients, and their parents, and their children, and their grandchildren, and you can see a line of problems if it is someone with drug addiction problems, it is very evident and we see it.
Last modified: May 31, 2013
Related Items by Category
What are the four domains to consider for assessing pain outcomes?
Knowledge Library published on May 17, 2013 in Assess & Monitor
What recommended tools are short, easy to administer & assist in predicting opioid use disorder?
Knowledge Library published on March 29, 2013 in Assess & Monitor
Can UDT be used to confirm diagnosis of drug addiction or physical dependence?
Knowledge Library published on June 15, 2012 in Assess & Monitor
How do you assess analgesia in patients with cognitive impairment or limited ability to communicate?
Knowledge Library published on May 25, 2012 in Assess & Monitor
How does pain education differ from other types of education?
Knowledge Library published on May 11, 2012 in Assess & Monitor
What does the absence of an expected drug in urine mean?
Knowledge Library published on April 13, 2012 in Assess & Monitor
Can UDT results be a sole indicator of adherence to prescribed opioids?
Knowledge Library published on March 2, 2012 in Assess & Monitor
Should clinicians require UDT on only those patients who are exhibiting aberrant behaviors?
Knowledge Library published on November 11, 2011 in Assess & Monitor
Why should we use UDT in our pain practices?
Knowledge Library published on September 9, 2011 in Assess & Monitor
Related Items by Author
Can these PDMPs be accessed across states?
Kathryn L. Hahn, PharmD, DAAPM, CPE
Knowledge Library published on May 24, 2013 in Practice
Are all the PDMPs operationally the same?
Kathryn L. Hahn, PharmD, DAAPM, CPE
Knowledge Library published on May 10, 2013 in Practice
How often should the database be accessed? After each prescription or periodically?
Kathryn L. Hahn, PharmD, DAAPM, CPE
Knowledge Library published on April 12, 2013 in Practice
What is the goal of the PDMP?
Kathryn L. Hahn, PharmD, DAAPM, CPE
Knowledge Library published on March 15, 2013 in Practice
As a pharmacist, a physician, or a nurse, do I have to be registered to access the PDMP?
Kathryn L. Hahn, PharmD, DAAPM, CPE
Knowledge Library published on February 8, 2013 in Practice
When is the best time to access the PDMP database?
Kathryn L. Hahn, PharmD, DAAPM, CPE
Knowledge Library published on January 4, 2013 in Practice
How can I find out if my state has a PMP?
Kathryn L. Hahn, PharmD, DAAPM, CPE
Knowledge Library published on May 4, 2012 in Practice
What are some key counseling points pharmacists should make when talking to patients about opioids?
Kathryn L. Hahn, PharmD, DAAPM, CPE
Knowledge Library published on March 30, 2012 in Practice
What is the safest way to dispose of unused opioids? Can I simply "flush" them down the drain?
Kathryn L. Hahn, PharmD, DAAPM, CPE
Knowledge Library published on November 23, 2011 in Safety/ADRs/SEs